Cognition Therapeutics Publishes Biomarker Findings from Clinical Study of CT1812 Supporting Positive Impact on Synapse Biology
February 10, 2021 08:00 ET
|
Cognition Therapeutics, Inc.
Pittsburgh, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular...
Cognition Therapeutics Publishes Evidence Identifying Receptor Integral in Parkinson’s Disease Pathology
February 01, 2021 08:00 ET
|
Cognition Therapeutics, Inc.
PITTSBURGH, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular...
Intelligent Drug Discovery Market Size To Be Worth USD 3,711.8 Million by 2027 | Emergen Research
December 09, 2020 13:00 ET
|
Emergen Research
Vancouver, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The Global Intelligent Drug Discovery Market is forecast to be worth USD 3,711.8 Million by 2027, according to a current analysis by...
Neurodegenerative Diseases Drugs Market Expands at 7.2% CAGR and Hit USD 62,786.2 Million by 2026; Biogen and F. Hoffmann-La Roche Ltd Cover More than Half of the Share: Fortune Business Insights
November 12, 2020 02:52 ET
|
Fortune Business Insights
Pune, Nov. 12, 2020 (GLOBE NEWSWIRE) -- The global neurodegenerative diseases drugs market size is expected to derive growth from the rising prevalence of neurodegenerative diseases especially among...
Cognition Therapeutics Appoints Brett P. Monia to its Board of Directors
October 27, 2020 08:00 ET
|
Cognition Therapeutics, Inc.
Pittsburgh, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular...
Artificial Intelligence in Drug Discovery Market To Reach USD 2.13 Billion By 2027 | Reports and Data
April 23, 2020 15:00 ET
|
Reports and Data
New York, April 23, 2020 (GLOBE NEWSWIRE) -- According to Reports and Data, the Artificial Intelligence in Drug Discovery Market was valued at USD 253.8 million in 2019 and is expected to reach USD...
Neurodegenerative Diseases Drugs Market to Reach US$ 62,786.2 Mn by 2026, Biogen and F. Hoffmann-La Roche Ltd Cover More than Half of the Share: Fortune Business Insights
July 25, 2019 11:25 ET
|
Fortune Business Insights
Pune, July 25, 2019 (GLOBE NEWSWIRE) -- The global neurodegenerative diseases drugs market’s growth is expected to derive growth from the rising prevalence of neurodegenerative diseases...
Servier backs an American startup at LabCentral in the field of mitochondrial health for neurodegenerative and rare diseases
November 14, 2018 02:00 ET
|
LabCentral
PARIS, France and CAMBRIDGE, Mass. USA, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Servier, an independent international pharmaceutical laboratory, and LabCentral, a well-known launchpad for innovative life...
DiamiR Announces Oral Presentation at AD/PD(TM) 2017
March 29, 2017 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 29, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Samuil...
DiamiR Awarded $2.75M Grant for Development of CogniMIR(TM) for Early Detection of Alzheimer's Disease
March 15, 2017 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 15, 2017) - DiamiR, LLC, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the National Institute...